Patents by Inventor Junichi Hirahashi

Junichi Hirahashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITOR OF EXTRACELLULAR TRAP FORMATION IN LEUKOCYTE
    Publication number: 20170296629
    Abstract: An object of the present invention is to provide a novel drug inhibiting extracellular trap formation in leukocytes. The present invention provides an inhibitor of extracellular trap formation in leukocytes containing a lactoferrin fragment, and a composition containing lactoferrin for treating a disease related to the extracellular trap formation in leukocytes.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 19, 2017
    Applicants: KEIO UNIVERSITY, NRL PHARMA, INC.
    Inventors: Junichi HIRAHASHI, Koshu OKUBO, Hiroshi KAWAKAMI, Shinji KAGAYA
  • INHIBITOR OF EXTRACELLULAR TRAP FORMATION IN LEUKOCYTES
    Publication number: 20160067315
    Abstract: The present invention has an object of providing a novel drug inhibiting formation of leukocyte extracellular traps. The present invention provides a lactoferrin-containing inhibitor of formation of leukocyte extracellular traps, and a lactoferrin-containing composition for treating a disease associated with the formation of the leukocyte extracellular traps.
    Type: Application
    Filed: April 8, 2014
    Publication date: March 10, 2016
    Inventors: Junichi HIRAHASHI, Yasuteru URANO, Koushu OKUBO, Mako KAMIYA, Shinji KAGAYA
  • THERAPEUTIC AGENT FOR ANCA-RELATED VASCULITIS
    Publication number: 20110152223
    Abstract: Disclosed is an agent for preventing/treating ANCA-related vasculitis and/or preventing the recurrence of ANCA-related vasculitis. Also disclosed is a therapeutic method using the agent. Specifically disclosed is a pharmaceutical composition comprising at least one member selected from the group consisting of eicosapentaenoic acid, a pharmaceutically acceptable salt thereof and an ester thereof as an active ingredient. The pharmaceutical composition is useful for the prevention of recurrence of ANCA-related vasculitis, the treatment of chronic ANCA-related vasculitis, and the prevention and treatment of rapidly progressive glomerulonephritis (RPGN).
    Type: Application
    Filed: August 21, 2009
    Publication date: June 23, 2011
    Inventors: Junichi Hirahashi, Makoto Arita, Keiichi Hishikawa, Toshiro Fujita, Masanori Nakakuki